Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities Growth (3y) (2023 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.38 Bn | 40.30 Bn | 1.44 Bn | 13.86% |
| 2 | Medpace Holdings | 16.51 Bn | 16.01 Bn | 201.64 Mn | -41.30% |
| 3 | Charles River Laboratories International | 13.16 Bn | 12.97 Bn | 452.07 Mn | 33.27% |
| 4 | Icon | 12.39 Bn | 11.46 Bn | 479.29 Mn | -38.69% |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 9.04% |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 419.14 Mn | 334.60 Mn | 18.44 Mn | 44.03% |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn | 32.09% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 217.20% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.03% |
| Mar 31, 2026 | 47.23% |
| Dec 31, 2025 | 47.33% |
| Sep 30, 2025 | -16.14% |
| Jun 30, 2025 | -63.33% |
| Mar 31, 2025 | -76.74% |
| Dec 31, 2024 | -72.07% |
| Sep 30, 2024 | 30.59% |
| Jun 30, 2024 | -3.90% |
| Mar 31, 2024 | 19.30% |
| Dec 31, 2023 | -17.42% |